Screening and active surveillance in prostate cancer: the dilemma continues

BJU Int. 2024 Jul;134(1):1-2. doi: 10.1111/bju.16345. Epub 2024 Mar 21.

Authors

Freddie C Hamdy¹, Peter C Albertsen², Jenny L Donovan³

Affiliations

¹ University of Oxford, Oxford, UK.
² UConn Health, Farmington, Connecticut, USA.
³ University of Bristol, Bristol, UK.

PMID: 38514989
DOI: 10.1111/bju.16345

No abstract available

Publication types

Editorial

MeSH terms

Early Detection of Cancer*
Humans
Male
Prostate-Specific Antigen / blood
Prostatic Neoplasms* / diagnosis
Watchful Waiting*

Substances

Prostate-Specific Antigen